TNK-651
TNK-651 is a non-nucleoside HIV-1 reverse transcriptase inhibitor. TNK-651 exhibits inhibitory effects on both the HIV-1 SF33 strain and the NNRTI-resistant HIV-1 A17 strain. TNK-651 can be used for the study of HIV-1 infection[1].
Product Specifications
CAS Number
[175739-42-1]
UNSPSC
12352005
Target
HIV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C1C(C(C)C)=C(CC2=CC=CC=C2)N(COCC3=CC=CC=C3)C(N1)=O
Molecular Formula
C22H24N2O3
Molecular Weight
364.44
References & Citations
[1]Wang X, et al. Design, synthesis, and biological evaluation of 1-[ (2-benzyloxyl/alkoxyl) methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15232236 1 Vial
Lentiviral mouse Arrdc5 shRNA (UAS) - Lentiviral mouse Arrdc5 shRNA (UAS, RFP) (100)
Ask
View Details MBS1263302-01 0.02 mg (E-Coli)
Recombinant Rhodospirillum centenum DNA-directed RNA polymerase subunit alpha (rpoA)
Ask
View Details MBS1263302-02 0.02 mg (Yeast)
Recombinant Rhodospirillum centenum DNA-directed RNA polymerase subunit alpha (rpoA)
Ask
View Details MBS1263302-03 0.1 mg (E-Coli)
Recombinant Rhodospirillum centenum DNA-directed RNA polymerase subunit alpha (rpoA)
Ask
View Details